Of note, venetoclax-resistant DLBCL lines with a MYC translocation/amplification, only a BCL2 translocation/amplification, or lacking these showed ETC sensitivity, indicating that ETCi sensitivity did not require these genetic events. Here, BCL2 is linked to diffuse large B-cell lymphoma.